India Pharmaceutical Industry Expected to Skyrocket in Coming Years by Favorable Government Policies
According to Goldstein Research, India is supplier of approximately 20% of generic medicines across the globe, in terms of volume which makes it a largest provider of generic medicines globally and the volumes are projected to expand in coming years. Huge expenditures by the Indian government to modernize the healthcare infrastructure and market players significant investment over R&D activities is also driving the growth of pharmaceutical industry in India. India Pharmaceutical market outlook also includes new business models, technological advancements, and capital investment as the key strategies adopted by the major players for significant expansion of business in India. Furthermore, Epidemiological factors such as 20% growth in patient pool, new diseases and increasing pervasiveness of lifestyle diseases will boost the pharmaceuticals industry in India. Browse Full Report: https://www.goldsteinresearch.com/report/india-pharmaceutical-market-industry-overview Marke...